Changes in quality of life (QoL) and other patient-reported outcome measures (PROMs) in living-donor and deceased-donor kidney transplant recipients and those awaiting transplantation in the UK ATTOM programme: a longitudinal cohort questionnaire survey with additional qualitative interviews.
Andrea GibbonsJanet BayfieldMarco CinnirellaHeather DraperRachel J JohnsonGabriel C OniscuRommel RavananCharles TomsonPaul RoderickWendy MetcalfeJohn L R ForsytheChristopher DudleyChristopher J E WatsonJ Andrew BradleyClare BradleyPublished in: BMJ open (2021)
While cross-sectional analyses suggested LD kidney transplantation leads to better QoL and treatment satisfaction, longitudinal assessment showed similar QoL improvements in PROMs for both transplant groups, with better outcomes than for those still wait-listed. Regardless of transplant type, clinicians need to be aware that managing expectations is important for facilitating patients' adjustment post-transplant.
Keyphrases
- cross sectional
- patient reported outcomes
- kidney transplantation
- patient reported
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- systematic review
- peritoneal dialysis
- type diabetes
- mesenchymal stem cells
- metabolic syndrome
- bone marrow
- skeletal muscle
- psychometric properties
- glycemic control
- cell therapy